Pfizer Inc
NYSE: PFE
$25.60
-$0.01 (0.0%)
Real Time Data Delayed 15 Min.
PFE Articles
Dogs of the Dow is a dividend strategy for investors to buy what are either "cheap" or "beaten up" Dow stocks. Unfortunately, 2015 was an awful year for the members of the Dogs of the Dow.
Published:
Last Updated:
These companies all provide drugs and medical devices that help hundreds of thousands of people daily lead a better life. They make good sense for conservative portfolios looking for income and...
Published:
Last Updated:
The short interest data have been released for the December 15 settlement date, and for most of the selected pharmaceutical stocks short interest was up.
Published:
Last Updated:
General Electric saw its short interest drop sharply again between the November 30 and December 15 settlement dates.
Published:
Last Updated:
December 24, 2015: Markets opened mixed on Thursday after thin trading and little movement in both Europe and Asia. The report on U.S. jobless claims was better than expected, but weakness in some...
Published:
Last Updated:
24/7 Wall St. screened the Jefferies Franchise Picks list for the top-yielding stocks and found four with outstanding growth potential.
Published:
Last Updated:
December 21, 2015: Markets opened higher on Monday following a changing of the guard at the top of Spain’s government and new hope for another dose of government stimulus in China. A weaker...
Published:
Last Updated:
At the end of every year, myriad strategies are announced for the coming year. With investors continuing to love dividends, one strategy that is reviewed every year is the so-called Dogs of the Dow.
Published:
Last Updated:
Amgen is getting aggressive enough on its dividend payout that you might think the biotech giant is now just a Big Pharma stock.
Published:
Last Updated:
Merrill Lynch is among the first firms to present their top picks for 2016, a decidedly conservative set of picks, and probably with good reason.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was up.
Published:
Last Updated:
Brokerage firm Jefferies has released its top pharmaceutical picks for the coming year and what to expect.
Published:
Last Updated:
With the market very possibly poised for years of sideways trading and single-digit gains, the total return potential from these blue chips is outstanding.
Published:
Last Updated:
December 2, 2015: Markets opened mixed on Wednesday and only the Nasdaq Composite was able to remain in positive territory until the afternoon release of the Fed’s Beige Book. U.S. crude oil...
Published:
Last Updated:
December 1, 2015: Markets opened higher on again on Tuesday and, unlike yesterday, held on to the gains for the most of the day. Equities took their cue from markets in Asia and Europe, both broadly...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.